Ubs Group Ag Oramed Pharmaceuticals Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Ubs Group Ag holds 28,184 shares of ORMP stock, worth $67,077. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,184
Previous 9,291
203.35%
Holding current value
$67,077
Previous $23,000
195.65%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding ORMP
# of Institutions
63Shares Held
7.4MCall Options Held
4KPut Options Held
2.1K-
Bml Capital Management, LLC Zionsville, IN2.19MShares$5.2 Million3.14% of portfolio
-
Murchinson Ltd. Toronto, A61.71MShares$4.07 Million1.22% of portfolio
-
Boothbay Fund Management, LLC New York, NY828KShares$1.97 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$872,0342.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$689,7310.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $92.4M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...